NCT01246765 National Pregnancy Registry for Psychiatric Medications
| NCT ID | NCT01246765 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Massachusetts General Hospital |
| Condition | Pregnant Women |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2008-11 |
| Primary Completion | 2033-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2008-11 with a primary completion date of 2033-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The National Pregnancy Registry for Psychiatric Medications is dedicated to evaluating the safety of psychiatric medications such as antidepressants, ADHD medications, sedative hypnotics, and atypical antipsychotics that many people take during pregnancy to treat a wide range of mood, anxiety, executive function, or psychiatric disorders. The goal of this Registry is to gather information on the safety of these medications during pregnancy, as current data is limited.
Eligibility Criteria
Inclusion Criteria: * Pregnant women * Age 18-45 * Subjects will be willing to participate over the phone * Subjects will be able to provide informed consent Exclusion Criteria: * Women who have completed their pregnancy * Women who are planning to become pregnant * Women who are not taking any psychiatric medications and/or have no history of psychiatric illness
Contact & Investigator
Lee S Cohen, MD
PRINCIPAL INVESTIGATOR
Massachusetts General Hospital
Frequently Asked Questions
Who can join the NCT01246765 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 45 Years, studying Pregnant Women. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT01246765 currently recruiting?
Yes, NCT01246765 is actively recruiting participants. Contact the research team at brediger@partners.org for enrollment information.
Where is the NCT01246765 trial being conducted?
This trial is being conducted at Boston, United States.
Who is sponsoring the NCT01246765 clinical trial?
NCT01246765 is sponsored by Massachusetts General Hospital. The principal investigator is Lee S Cohen, MD at Massachusetts General Hospital. The trial plans to enroll 5,000 participants.